Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Houjou

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|January 1, 1993
Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumorT Houjou, T Wada, M Yasutomi
Anticancer Research|November 1, 1993
A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinomaT Wada, T Houjou, R Kubo, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1997
Biodistribution of cyclosporin encapsulated in liposomes modified with bioadhesive polymerY Yoshikawa, M Miyazaki, T Houjou, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1991
[The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer]K Kadota, T Wada, M Watatani, et al.
Nihon Jinzo Gakkai Shi|September 30, 1998
[Aldehyde dehydrogenase 2(ALDH2) gene polymorphism in NIDDM patients with chronic renal failure]S Kuriyama, Y Suzuki, Y Atsumi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1990
[Clinical evaluation of estramustine phosphate in the treatment of patients with advanced breast cancers]T Wada, E Morikawa, T Houjou, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1996
Oral sustained-release cisplatin capsuleT Houjou, K Nakano, O Ike, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers]T Wada, N Matunami, T Houjou, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|January 1, 1993
Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumorT Houjou, T Wada, M Yasutomi
Anticancer Research|November 1, 1993
A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinomaT Wada, T Houjou, R Kubo, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1997
Biodistribution of cyclosporin encapsulated in liposomes modified with bioadhesive polymerY Yoshikawa, M Miyazaki, T Houjou, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1991
[The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer]K Kadota, T Wada, M Watatani, et al.
Nihon Jinzo Gakkai Shi|September 30, 1998
[Aldehyde dehydrogenase 2(ALDH2) gene polymorphism in NIDDM patients with chronic renal failure]S Kuriyama, Y Suzuki, Y Atsumi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1990
[Clinical evaluation of estramustine phosphate in the treatment of patients with advanced breast cancers]T Wada, E Morikawa, T Houjou, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1996
Oral sustained-release cisplatin capsuleT Houjou, K Nakano, O Ike, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers]T Wada, N Matunami, T Houjou, et al.
Pageof 1